Home
The War on Cancer
Cancer A – Z
Drug Approvals 2017
Articles
Conference Coverage
Editorial
Eric Rosenthal Reports
Expert Interview
Latest Articles
Publications
News
The Onco’Zine Brief
The Onco’Zine Brief Episodes
Upcoming Programs | Shows
How to Support The Onco’Zine Brief
Underwriting
The Onco’Zine Brief on PRX
The Onco’Zine Brief on Spreaker
Programs | Shows
Oncology Directory
Join Today
Event Agenda
Video
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Home
The War on Cancer
Cancer A – Z
Drug Approvals 2017
Articles
Conference Coverage
Editorial
Eric Rosenthal Reports
Expert Interview
Latest Articles
Publications
News
The Onco’Zine Brief
The Onco’Zine Brief Episodes
Upcoming Programs | Shows
How to Support The Onco’Zine Brief
Underwriting
The Onco’Zine Brief on PRX
The Onco’Zine Brief on Spreaker
Programs | Shows
Oncology Directory
Join Today
Event Agenda
Video
Home
Cancer Risk
Cancer Risk
Addressing Disparities in Cancer: Factors Influencing Care, Access and Outcomes
Peter Hofland, Ph.D
-
December 8, 2019
ASH 2019: Real-World Data of Apixaban in Venous Thromboembolism Patients with Cancer
Tivozanib Improved PFS and was better Tolerated Compared with Sorafenib in Patients with mRCC.
Enfortumab Vedotin + Pembrolizumab to be Evaluated in Metastatic Bladder Cancer
Study Identifies Cells-of-origin of High-grade Serous Ovarian Cancer
Study Shows – More Children being Diagnosed with Neuroblastoma but Survival...
Peter Hofland, Ph.D
-
November 25, 2019
Disparities in Appalachian Breast Cancer Patients
Peter Hofland, Ph.D
-
November 20, 2019
Poor Patients Treated Outside NCI Centers Less Likely to Receive Expensive...
Peter Hofland, Ph.D
-
November 19, 2019
Study Shows Oxygen-starved Cancer Cells have a Survival Advantage Promoting Cancer...
Peter Hofland, Ph.D
-
November 7, 2019
Cancer Type and Incidence Among American Indians and Alaska Natives Varies...
Danielle Garcia
-
October 2, 2019
Some, but not all, Breast Cancer Patients Could Benefit from Aspirin
Danielle Garcia
-
August 12, 2019
Women with HIV have Higher Prevalence of Anal High-grade Squamous Intraepithelial...
Peter Hofland, Ph.D
-
July 21, 2019
New Immunotherapy Strategy Offers Potential for Liver Cancer Treatment while Reducing...
Peter Hofland, Ph.D
-
July 20, 2019
A Low-Fat Diet Helps Reduce Risk of Death From Breast Cancer...
Danielle Garcia
-
May 18, 2019
Study Shows Some Elderly Cancer Survivors may Face Risk of Brain...
Danielle Garcia
-
May 17, 2019
1
2
3
...
6
Page 1 of 6
LATEST
ASH 2019: Brentuximab Vedotin in Combination with Nivolumab in Frontline and R/R Hodgkin Lymphoma
Editorial Team
-
December 8, 2019
ASH 2019: Second-gen CAR T-Cell Therapy Overcome Resistance, Reduce Toxicity and Simplify Treatment
Peter Hofland, Ph.D
-
December 8, 2019
Addressing Disparities in Cancer: Factors Influencing Care, Access and Outcomes
Peter Hofland, Ph.D
-
December 8, 2019